Circius Pharma ApS: Financial statements 2022
CVR: 42447641
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Circius Pharma ApS (CVR 42447641) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,765,694 and a net result of DKK -15,906. Equity in the 2022 report amounted to DKK 5,679,770. The solvency ratio was 58%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,765,694
- Profit/Loss
- DKK -15,906
- Equity
- DKK 5,679,770
- Total Assets
- DKK 9,796,767
- Employees
- 2
Official annual report
Keep an eye on Circius Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Circius Pharma ApS has published its interim report for the period June 1, 2021 – December 31, 2021.
About Circius Pharma ApS
Circius Pharma ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Erik Gustav Smith, Jan Gustav Smith and Johan Lindberg. The company is owned by Circius Pharma AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,858,282 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 3,437,320.